Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio V Scagliotti

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancerGiorgio V Scagliotti
Seminars in Oncology|April 9, 2005
Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancerGiorgio V Scagliotti
Expert Opinion on Investigational Drugs|May 2, 2003
Pemetrexed and its emerging role in the treatment of thoracic malignanciesGiorgio V Scagliotti, Silvia Novello
Current Oncology Reports|June 5, 2003
Adjuvant therapy in completely resected non-small-cell lung cancerGiorgio V Scagliotti, Silvia Novello
Clinical Lung Cancer|January 11, 2005
Current development of adjuvant treatment of non-small-cell lung cancerGiorgio V Scagliotti, Silvia Novello
Critical Reviews in Oncology/Hematology|June 28, 2005
Management of bone metastases in cancer: a reviewGiovanni Selvaggi, Giorgio V Scagliotti
Seminars in Oncology|August 15, 2003
Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approachGiorgio V Scagliotti, Silvia Novello
Oncology (Williston Park, N.Y.)|January 2, 2010
Histologic subtype in NSCLC: does it matter?Giovanni Selvaggi, Giorgio V Scagliotti
Expert Opinion on Therapeutic Patents|February 11, 2010
Antimetabolites and cancer: emerging data with a focus on antifolatesGiorgio V Scagliotti, Giovanni Selvaggi
Current Opinion in Pulmonary Medicine|April 30, 2021
The evolving paradigm of precision medicine in lung cancerFrancesco Passiglia, Giorgio V Scagliotti
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancerGiorgio V Scagliotti
Seminars in Oncology|April 9, 2005
Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancerGiorgio V Scagliotti
Expert Opinion on Investigational Drugs|May 2, 2003
Pemetrexed and its emerging role in the treatment of thoracic malignanciesGiorgio V Scagliotti, Silvia Novello
Current Oncology Reports|June 5, 2003
Adjuvant therapy in completely resected non-small-cell lung cancerGiorgio V Scagliotti, Silvia Novello
Clinical Lung Cancer|January 11, 2005
Current development of adjuvant treatment of non-small-cell lung cancerGiorgio V Scagliotti, Silvia Novello
Critical Reviews in Oncology/Hematology|June 28, 2005
Management of bone metastases in cancer: a reviewGiovanni Selvaggi, Giorgio V Scagliotti
Seminars in Oncology|August 15, 2003
Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approachGiorgio V Scagliotti, Silvia Novello
Oncology (Williston Park, N.Y.)|January 2, 2010
Histologic subtype in NSCLC: does it matter?Giovanni Selvaggi, Giorgio V Scagliotti
Expert Opinion on Therapeutic Patents|February 11, 2010
Antimetabolites and cancer: emerging data with a focus on antifolatesGiorgio V Scagliotti, Giovanni Selvaggi
Current Opinion in Pulmonary Medicine|April 30, 2021
The evolving paradigm of precision medicine in lung cancerFrancesco Passiglia, Giorgio V Scagliotti
Pageof 16